Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026
Stocks in this Quantisnow insightHealth Care
Historical context for DBVT
Across the 26 sessions after earlier DBVT headlines, the stock closed higher 9 times and lower 17 times, with a median move of 3.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | DBVT | SPY |
|---|---|---|---|
| Jul 31, 2026 | DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq | -2.2% | +0.7% |
| Jul 20, 2026 | DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales | -0.9% | -0.2% |
| Jul 17, 2026 | DBV Technologies Announces the Filing of its 2026 Half-Year Report ― Conditions for Accessing or Consulting the Reportand 1 other headline that session | -1.1% | -1.0% |
| Jul 15, 2026 | DBV Technologies to Report Second Quarter 2026 Financial Results and Business Update on July 16, 2026 | -1.3% | +0.4% |
| Jul 7, 2026 | Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF | +11.1% | -0.5% |
| Jun 30, 2026 | DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing | +2.5% | +0.8% |
Quantisnow market dataNASDAQ
DBVT
DBV Technologies S.A.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2014
Get push alerts for DBVT
Full DBVT profile on Quantisnow Follow DBVT and get a push notification the moment its next story breaks.